ORMP icon

Oramed Pharmaceuticals

31 hedge funds and large institutions have $1.97M invested in Oramed Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

39% less capital invested

Capital invested by funds: $3.21M → $1.97M (-$1.25M)

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$583K
Puts
$550K
Net Calls
Net Calls Change

Top Buyers

1 +$219K
2 +$119K
3 +$113K
4
Millennium Management
Millennium Management
New York
+$40K
5
UBS Group
UBS Group
Switzerland
+$23.4K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$573K
2
$235K
3
$219K
4
$140K
5
$119K
6
$113K
7
$97K
8
$64K
9
$51K
10
$51K
11
$46K
12
$40K
13
$26K
14
$24K
15
$23K
16
$20K
17
$19K
18
$17K
19
$15K
20
$12K
21
$12K
22
$11K
23
$9K
24
$9K
25
$5K